resorcinol has been researched along with resacetophenone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldasso, P; Calgarotto, AK; Comar, M; da Silva, SL; Damico, DC; Marangoni, S; Maso, V; Oliveira, AR; Oliveira, KM; Veber, CL; Villar, JA | 1 |
| Enya, T; Fukuda, K; Komatsu, H; Matsushima-Hibiya, Y; Mutoh, H; Mutoh, M; Sugimura, T; Takahashi, M; Wakabayashi, K | 1 |
2 other study(ies) available for resorcinol and resacetophenone
| Article | Year |
|---|---|
Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.
Topics: Animals; Crotalid Venoms; Drug Design; Edema; Enzyme Inhibitors; Humans; Kinetics; Models, Molecular; Phenols; Phospholipase A2 Inhibitors | 2009 |
Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship.
Topics: Acetophenones; Colonic Neoplasms; Cyclooxygenase 2; Electrons; Flavonoids; Genes, Reporter; Humans; Inhibitory Concentration 50; Isoenzymes; Membrane Proteins; Oxygen; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Quercetin; Resorcinols; Structure-Activity Relationship; Transcription, Genetic; Tumor Cells, Cultured | 2000 |